Articles Tagged With:
-
Alternative Dispute Resolution Underused in Most Hospitals
Hospitals have been slow to make use of alternative dispute resolution (ADR) agreements to avoid litigation and bring about more satisfactory conclusions to claims.
-
Executive Protection May Need Review After CEO Killing
The shooting of Brian Thompson in December 2024 has brought attention to the security needs of healthcare executives, with some in the industry suggesting that organizations should devote resources to increased protection.
-
How You Respond to Lawsuit Notices Makes the Difference
Receiving notice of a lawsuit can ruin any risk manager’s day, but how you respond can dictate the ultimate outcome. The best approach is to have a plan in place and execute it carefully once you receive the news.
-
Evaluation and Management of Diplopia in the Emergency Department
Diplopia is an uncommon presenting complaint in the emergency department that can be associated with life- and vision-threatening diagnoses. Comprehensive management typically requires an interdisciplinary team, often including both ophthalmology and neurology. This article provides emergency physicians with an organized resource that they can quickly reference for guidance on the assessment, management, and disposition of diplopia patients.
-
Infectious Disease Updates
Two-Step Testing for Anal Cancer Screening in HIV; Reducing Complications of PICCs; Plan for the Lifecycle of a PICC
-
Diphtheria Surge in Europe
A marked increase in cases of diphtheria in Europe is related to migrants, most often from Syria or Afghanistan, indicating a need to maintain high levels of immunity through vaccination, not only in Europe but everywhere, including the United States.
-
Pemivibart for COVID-19 Prophylaxis: Clinical Trial Confirms its Efficacy
Confirming the results of the immunobridging analysis that led to its initial authorization for emergency use, this study demonstrates that pemivibart is effective as prophylaxis against COVID-19, including in immunocompromised patients.
-
What Is New with Leptospirosis?
Leptospirosis continues to cause seasonal problems in some urban areas, especially those with large populations of rats and imperfect garbage handling. New diagnostic tests are being developed, and plasma exchange offers the potential of improved outcomes for patients with leptospirosis accompanied by severe pulmonary hemorrhage.
-
Patients Hospitalized for Nonsevere COVID-19: No Benefit of CAP Antibiotics
A large population-based, retrospective, cohort study found there was no benefit for antibiotics targeting community-acquired pneumonia in patients hospitalized with nonsevere COVID-19. These results provide evidence against antibiotic use in this population.
-
Early Preoperative Antibiotics Before Appendectomy
Pre-incision treatment did not reduce intra-operative perforation, and likewise did not change purulent contamination, peri-appendicular abscess, or histologic gangrene. It did lower 30-day surgical-site infection (SSI) (1.6% vs. 3.2%; P = 0.03) and re-intervention for SSI (0.3% vs. 1.1%), but the effect was marginally significant, giving a number-needed-to-treat of 63 for any SSI and 125 for a re-intervention.